GH1 and breast carcinoma: Studies on rodents and human mammary carcinoma cells implicate that prolactin, growth hormone (GH), EGF, and IGF-I act as inhibitors of TGF-β1 expression in MECs, while somatostatin and sex steroids are shown to stimulate the expression.